Novacyt SA (LSE:NCYT) - Share price


Stock Report

Novacyt SA NCYT

Last Price
GBX316.00

Day Change
11.00|3.61%

As of 29/05/2020
17:55:59 BST | GBX
Minimum 15 Minutes Delay.

Last Close305.00p
Day Range297.00 - 328.78
Mkt Cap214.20Mil
52-Wk Range6.03 - 529.00
Yield %-
ISINFR0010397232
Volume811,474
P/E-
P/S8.68
P/CF-95.76

Share Price

Total Returns 29/05/2020

 Chg (%)  
More ...
Novacyt SA-21.98 
FTSE 100 TR GBP3.34
 
Financials
201620172018
More ...
Income Statement
Turnover11.0812.7513.72
Operating Profit-3.06-0.10-0.63
Net Profit-5.71-3.49-2.11
Reported EPS-0.47-0.15-0.06
Balance Sheet
Current Assets7.3610.917.72
Non Current Assets23.0823.1222.50
Total Assets30.4434.0232.51
Current Liabilities8.827.799.90
Total Liabilities---
Total Equity17.7724.9120.14
Cash Flow
Operating Cash Flow-2.26-4.50-1.44
Net Change in Cash1.271.52-3.20
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
25/05/2020PurchaseMr. Jean-Pierre Jacques Crinelli3.385,89919,927.00
15/05/2020PurchaseGraham D. Mullis310.009,49329,428.00
15/05/2020PurchaseMr. James Christopher Wakefield304.9020,00060,980.00

Company Profile

Novacyt SA develops and markets solutions in medical cytology. It offers portfolio of cancer and infectious disease diagnostics products and services. It has three reportable segment, Cytology, Diagnostics and Molecular Testing.

Sector

Diagnostics & Research

Index

Next Event 05/06/2020

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-6.18
Op Mrgn-0.05
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerGraham D. Mullis
Non-Executive DirectorDr. Andrew John William Heath
Non-Executive DirectorDr. Edwin Snape
Executive Director, Chief Financial Officer and Company SecretaryMr. Anthony Stephen Dyer
Non-Executive Director, ChairmanMr. James Christopher Wakefield
Non-Executive DirectorMr. Jean-Pierre Jacques Crinelli
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.